Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
DEEP SEA MINERALS CORP. SUBMITS APPLICATION TO NOAA UNDER DEEP SEABED HARD MINERAL RESOURCES ACT
-
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
-
QGold Resources Provides Corporate Update, Announces Preliminary Economic Assessment (PEA) Timeline and Management Transition to Advance Quartz Mountain Gold Project
-
SL Green Realty Corp. Announces Annual Ordinary Dividend of $2.47 per Share
-
Ridgepost Capital Announces Retirement of Mark Hood as EVP and CAO
-
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
-
Acture Solutions Receives Strategic Financing from Stonepeak Credit
-
TE Connectivity survey: Return on investment becomes top priority as AI age evolves
-
Ford and Major League Baseball Unite to Celebrate America’s Pastime and the People Who Power It
-
Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement
-
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
-
TWO Determines Unsolicited Proposal from CrossCountry Mortgage is a “Company Superior Proposal”
-
State Street Elects Susan Gordon to Its Board of Directors
-
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
-
Leading DC/Maryland Practice Expands Access to Premium, On-Demand Remote Pregnancy Monitoring with INVU™
-
Mobileye Secures Major DMS Production Program with Leading U.S. Automaker
-
ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule
-
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservat
-
Bombardier Announces Successful Completion of Consent Solicitation with Respect to its 7.450% Notes due 2034
-
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
FuelCell Energy Scales Up for Data Centers with Packaged 12.5 MW Utility‑Grade Power Block Solution and Manufacturing Expansion Plans
-
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
-
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
-
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
-
High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
-
Digi Power X to Announce 2025 Year End Financial Results on March 31st
-
Interna Therapeutics Announces Human Challenge Trial Agreement with the University of Oxford to Advance Intranasal MNM-siRNA SARS-CoV-2 Prophylaxis Program
-
Deepening the U.S.-Japan Alliance: U.S. Congress Introduces Historic Resolution Urging Japan to Legislate Ban on Dog and Cat Meat Consumption
-
Tesoro Minerals Closes Agreement with GlobeTrotters to Acquire Rumichaca and Cerro Macho in Peru
-
Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
-
DCL Introduces New Emissions Control Solution for Cleaner Backup Power at European Data Centers
-
NICHOLAS AIR the Premium Private Air Travel Provider Upgrades Fleet In-Flight Connectivity with Starlink
-
Air Canada Provides Update on Air Canada Express Flight AC8646
-
Snipp Interactive Secures US$3 Million Contract, Largest in Company History
-
Fitzroy Minerals Reports Wide Copper Mineralization Intervals From the Buen Retiro Copper Project, Chile, and Provides an Exploration Update
-
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
-
Alithya's industry insights reveal 2026 priorities and AI trends across financial services, manufacturing, and healthcare
-
JZXN to Deliver 100 Electric Heavy-Duty Trucks to Vietnam Market
-
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
-
WeRide Reports Record Full Year 2025 Revenue of RMB684.6 Million, Up 90% Year over Year
-
Financing agreement signed for CIMC-Hexagon joint venture
-
Townsend's Brookes Townsend to Run the 2026 Boston Marathon
-
Integrated DNA Technologies Expands into Clinical Diagnostics with First In Vitro Diagnostic
-
Notice of Extraordinary General Meeting of Jyske Bank A/S
-
Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics
-
IPG to Expand T20 Cricket Footprint Across Sri Lanka, Malaysia and Zimbabwe Following Merger with Flash Sports & Media, Inc., following Flash’s merger with NASDAQ-listed urban-gro, Inc.
-
IPG to Expand T20 Cricket Footprint Across Sri Lanka, Malaysia and Zimbabwe Following Merger with Flash Sports & Media, Inc., following Flash’s merger with NASDAQ-listed urban-gro, Inc.
-
Banc of California, Inc. Extends $300 Million Stock Repurchase Program and Announces Intent to Redeem Outstanding Fixed-to-Floating Rate Subordinated Notes due 2031
-
OR Royalties Appoints Mr. Patrick Godin to Its Board of Directors
